Take the MSToronto 2026 pre-congress survey

Question 1: Which of the following hot topics is most interesting/relevant to you? (pick one)

Question 2: About which of the following topics would you like more information? (pick any)

Question 3: Which of the following late-breaking studies is of greatest interest to you? (pick one)

Question 4: Which of the following clinical studies interests you the most? (pick any)

FENhance 1 and 2 pooled analysis of fenebrutinib in RMS
OVERLORD-MS trial of rituximab vs. ocrelizumab in newly-diagnosed MS
Database analysis of impact of early high-efficacy therapy vs. escalation on PIRA
SUPERNEXT study of personalized dosing of natalizumab
PREDISC-MS study of isolated MRI activity after treatment discontinuation
Breakfree-2 study of a CD19-directed CAR-T therapy in highly active and progressive MS

Question 5: About which oral disease-modifying therapy would you like more information? (pick any)

Question 6: About which monoclonal antibody disease-modifying therapy would you like more information? (pick any)

Question 7: Which of the following novel therapies is most interesting/relevant to you? (pick one)

Question 8: Which clinical question has the greatest relevance to you? (pick one)

NeuroSens